IMMUNOSUPPRESSIVE PROPERTIES OF ENISOPROST (ENO) AND A 5-LIPOXYGENASE INHIBITOR (5LO)

被引：0
|
作者：
LI, XW
WEIR, MR
GOMOLKA, D
PEPPLER, R
MORAN, M
OBRYANLEAR, G
机构：
[1] UNIV MARYLAND HOSP,BALTIMORE,MD 21201
[2] GD SEARLE & CO,SKOKIE,IL 60077
来源：
KIDNEY INTERNATIONAL | 1990年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [21] RBx 7796: A novel inhibitor of 5-lipoxygenase
    Shirumalla, R. K.
    Naruganahalli, K. S.
    Dastidar, S. G.
    Sattigeri, V.
    Kaur, G.
    Deb, C.
    Gupta, J. B.
    Salman, M.
    Ray, A.
    INFLAMMATION RESEARCH, 2006, 55 (12) : 517 - 527
  • [22] DIPYRIDAMOLE - A POTENT AND SPECIFIC 5-LIPOXYGENASE INHIBITOR
    CARTER, GW
    DYER, R
    YOUNG, P
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 904 - 904
  • [23] Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
    Kang, Kai-Hsiang
    Liou, Horng-Hui
    Hour, Mann-Jen
    Liou, Houng-Chi
    Fu, Wen-Mei
    NEUROPHARMACOLOGY, 2013, 73 : 380 - 387
  • [24] 5-LIPOXYGENASE
    FORDHUTCHINSON, AW
    GRESSER, M
    YOUNG, RN
    ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 : 383 - 417
  • [25] BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF 5-LIPOXYGENASE INHIBITOR KF8940
    KITAMURA, S
    HASHIZUME, K
    OHMORI, K
    KASE, H
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1988, 52 (12): : 3131 - 3136
  • [26] The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein
    Randy L. Bell
    Richard R. Harris
    Clinical Reviews in Allergy & Immunology, 1999, 17 : 91 - 109
  • [27] EXPRESSION OF 5-LIPOXYGENASE AND 5-LIPOXYGENASE ACTIVATION PROTEIN IN GLOMERULONEPHRITIS
    RIFAI, A
    SAKAI, H
    YAGAME, M
    KIDNEY INTERNATIONAL, 1993, 43 : S95 - S99
  • [28] The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein
    Bell, RL
    Harris, RR
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1999, 17 (1-2) : 91 - 109
  • [29] Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton
    Patel, NSA
    Cuzzocrea, S
    Chatterjee, PK
    Di Paola, R
    Sautebin, L
    Britti, D
    Thiemermann, C
    MOLECULAR PHARMACOLOGY, 2004, 66 (02) : 220 - 227
  • [30] CONVERSION OF A CYCLOOXYGENASE(CO) INHIBITOR INTO A 5-LIPOXYGENASE(LO) INHIBITOR - A GENERAL-ROUTE TO NOVEL ANTIALLERGY AND ANTIINFLAMMATORY DRUGS
    FAILLI, A
    KREFT, A
    MUSSER, J
    STEFFAN, R
    SHAH, U
    KUBRAK, D
    BANKER, A
    DEMERSON, C
    NELSON, J
    MARSHALL, L
    HOLLOWAY, D
    STURM, R
    CARLSON, R
    BERKENKOPF, J
    GRIMES, D
    WEICHMAN, B
    CHANG, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 179 - MEDI
12345